![Michael Scherz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Michael Scherz is the founder of Metys Pharmaceuticals AG, where he currently holds the title of Chief Executive Officer & Director.
He founded the company in 2013.
Michael Scherz active positions
Companies | Position | Start |
---|---|---|
Metys Pharmaceuticals AG
![]() Metys Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Part of Novaremed AG, Metys Pharmaceuticals AG is a pharmaceutical company based in Basel, Switzerland. The Swiss company specializes in developing dimiracetam for the prevention of chemotherapy-induced neuropathic pain. The company was founded by Michael Scherz, who has been the CEO since incorporation. Metys Pharmaceuticals was acquired by Novaremed AG on September 07, 2021. | Founder | 2012-12-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Metys Pharmaceuticals AG
![]() Metys Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Part of Novaremed AG, Metys Pharmaceuticals AG is a pharmaceutical company based in Basel, Switzerland. The Swiss company specializes in developing dimiracetam for the prevention of chemotherapy-induced neuropathic pain. The company was founded by Michael Scherz, who has been the CEO since incorporation. Metys Pharmaceuticals was acquired by Novaremed AG on September 07, 2021. | Health Technology |
- Stock Market
- Insiders
- Michael Scherz